company background image
HAZ

Haemonetics DB:HAZ Stock Report

Last Price

€80.50

Market Cap

€4.2b

7D

1.3%

1Y

87.2%

Updated

24 Jan, 2023

Data

Company Financials +

HAZ Stock Overview

Haemonetics Corporation, a healthcare company, provides medical products and solutions.

HAZ fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance5/6
Financial Health3/6
Dividends0/6

My Notes

New

Notes are coming soon

Haemonetics Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Haemonetics
Historical stock prices
Current Share PriceUS$80.50
52 Week HighUS$85.50
52 Week LowUS$38.60
Beta0.37
1 Month Change9.52%
3 Month Change0%
1 Year Change87.21%
3 Year Change-16.58%
5 Year Change53.71%
Change since IPO285.54%

Recent News & Updates

Recent updates

Shareholder Returns

HAZDE Medical EquipmentDE Market
7D1.3%-2.2%-0.07%
1Y87.2%-14.5%-8.7%

Return vs Industry: HAZ exceeded the German Medical Equipment industry which returned -19.3% over the past year.

Return vs Market: HAZ exceeded the German Market which returned -12.9% over the past year.

Price Volatility

Is HAZ's price volatile compared to industry and market?
HAZ volatility
HAZ Average Weekly Movement5.5%
Medical Equipment Industry Average Movement5.0%
Market Average Movement5.2%
10% most volatile stocks in DE Market10.2%
10% least volatile stocks in DE Market2.3%

Stable Share Price: HAZ is not significantly more volatile than the rest of German stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: HAZ's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19712,821Chris Simonhttps://www.haemonetics.com

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system.

Haemonetics Corporation Fundamentals Summary

How do Haemonetics's earnings and revenue compare to its market cap?
HAZ fundamental statistics
Market Cap€4.19b
Earnings (TTM)€79.19m
Revenue (TTM)€997.34m

52.9x

P/E Ratio

4.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
HAZ income statement (TTM)
RevenueUS$1.08b
Cost of RevenueUS$491.12m
Gross ProfitUS$592.60m
Other ExpensesUS$506.55m
EarningsUS$86.05m

Last Reported Earnings

Oct 01, 2022

Next Earnings Date

Feb 07, 2023

Earnings per share (EPS)1.70
Gross Margin54.68%
Net Profit Margin7.94%
Debt/Equity Ratio112.3%

How did HAZ perform over the long term?

See historical performance and comparison